Technical Analysis for HTGM - HTG Molecular Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 2.31 2.21% 0.05
HTGM closed up 2.21 percent on Friday, January 18, 2019, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical HTGM trend table...

Date Alert Name Type % Chg
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Oversold Stochastic Weakness 0.00%
Jan 17 20 DMA Resistance Bearish 2.21%
Jan 17 Stochastic Reached Oversold Weakness 2.21%
Jan 17 Oversold Stochastic Weakness 2.21%
Jan 16 Down 3 Days in a Row Weakness 2.21%
Jan 16 Down 4 Days in a Row Weakness 2.21%
Jan 16 Down 5 Days in a Row Weakness 2.21%
Jan 15 Down 3 Days in a Row Weakness 0.43%
Jan 15 Down 4 Days in a Row Weakness 0.43%

Older signals for HTGM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
HTG Molecular Diagnostics, Inc. develops and markets a technology platform that facilitates the routine use of complex molecular profiling. The company's HTG Edge platform consists of instrumentation, consumables, and software analytics that are used in sample profiling applications, including tumor profiling, molecular diagnostic testing, and biomarker development. The HTG Edge platform automates the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology comprising HTG Edge Immuno-oncology Assay, HTG Edge FGFR Expression Assay, HTG Edge DLBCL Cell of Origin Assay, HTG EdgeSeq microRNA Whole-transcriptome Assay, HTG Edge Top Oncogene Assay, and HTG Edge DMPK Assay. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States; and through distributors or sales agents in parts of Europe, India, and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Is HTGM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.83
52 Week Low 2.13
Average Volume 297,072
200-Day Moving Average 3.5092
50-Day Moving Average 3.012
20-Day Moving Average 2.448
10-Day Moving Average 2.448
Average True Range 0.2108
ADX 32.68
+DI 15.3372
-DI 24.3443
Chandelier Exit (Long, 3 ATRs ) 2.1976
Chandelier Exit (Short, 3 ATRs ) 2.7624
Upper Bollinger Band 2.7901
Lower Bollinger Band 2.1059
Percent B (%b) 0.3
BandWidth 27.949346
MACD Line -0.1874
MACD Signal Line -0.1913
MACD Histogram 0.004
Fundamentals Value
Market Cap 26.44 Million
Num Shares 11.4 Million
EPS -2.95
Price-to-Earnings (P/E) Ratio -0.78
Price-to-Sales 5.18
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.48
Resistance 3 (R3) 2.47 2.40 2.45
Resistance 2 (R2) 2.40 2.36 2.41 2.44
Resistance 1 (R1) 2.36 2.34 2.38 2.37 2.43
Pivot Point 2.29 2.29 2.31 2.30 2.29
Support 1 (S1) 2.25 2.25 2.27 2.26 2.19
Support 2 (S2) 2.18 2.23 2.19 2.18
Support 3 (S3) 2.14 2.18 2.17
Support 4 (S4) 2.15